Alerje Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 27

Alerje General Information

Description

Developer of emergency medicine and digital oral immunotherapy (OIT) management platform designed to improve the overall quality of life for those affected by food allergies. The company's epinephrine auto-injector integrates into a smartphone case for improved patient adherence improvement and alerts, enabling families, allergists, insurers, and pharma companies to make improved dietary decisions.

Contact Information

Website
www.alerje.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 440 Burroughs Street
  • Detroit, MI 48202
  • United States
+1 (313)
Primary Industry
Information Services (B2C)
Other Industries
Other Healthcare Technology Systems
Application Software
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • 440 Burroughs Street
  • Detroit, MI 48202
  • United States
+1 (313)

Alerje Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alerje Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Secondary Transaction - Private 07-Aug-2024 Completed Generating Revenue
13. Grant 07-Sep-2023 Completed Generating Revenue
12. Seed Round 10-Aug-2023 Completed Generating Revenue
11. Accelerator/Incubator 19-Dec-2022 Completed Generating Revenue
10. Accelerator/Incubator 02-Nov-2022 Completed Generating Revenue
9. Secondary Transaction - Private 01-Aug-2022 Completed Generating Revenue
8. Grant 01-Oct-2021 Completed Generating Revenue
7. Grant 20-Oct-2020 Completed Generating Revenue
6. Accelerator/Incubator 30-Sep-2020 $138K Completed Generating Revenue
5. Accelerator/Incubator 07-Oct-2019 $37.5K $138K Completed Generating Revenue
To view Alerje’s complete valuation and funding history, request access »

Alerje Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2
Seed-1 225,584 $0.000010 6% $0.09 $0.09 1x $0.09 1.3%
Seed 1,735,204 $0.000010 6% $0.58 $0.58 1x $0.58 3.05%
To view Alerje’s complete cap table history, request access »

Alerje Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Alerje Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023263511-A1 Method for predicting adverse symptoms to immunotherapy Inactive 11-Nov-2022
EP-4369349-A1 Method for predicting adverse symptoms to immunotherapy Pending 11-Nov-2022
US-20240161895-A1 Method for predicting adverse symptoms to immunotherapy Pending 11-Nov-2022
AU-2021308628-A1 System and method for monitoring and managing patients undergoing immunotherapy Inactive 16-Jul-2020
AU-2024227655-A1 System and method for monitoring and managing patients undergoing immunotherapy Pending 16-Jul-2020 G16H20/17
To view Alerje’s complete patent history, request access »

Alerje Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alerje Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accel Venture Capital Minority
Angel (individual) Minority
Chloe Capital Venture Capital Minority
CitySide Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 27 investors. Get the full list »

Ready to get started?

Request a free trial

Alerje FAQs

  • When was Alerje founded?

    Alerje was founded in 2016.

  • Where is Alerje headquartered?

    Alerje is headquartered in Detroit, MI.

  • What is the size of Alerje?

    Alerje has 7 total employees.

  • What industry is Alerje in?

    Alerje’s primary industry is Information Services (B2C).

  • Is Alerje a private or public company?

    Alerje is a Private company.

  • What is Alerje’s current revenue?

    The current revenue for Alerje is .

  • How much funding has Alerje raised over time?

    Alerje has raised $2.07M.

  • Who are Alerje’s investors?

    Accel, , Chloe Capital, CitySide Ventures, and are 5 of 27 investors who have invested in Alerje.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process